Objective-Aortic calcification is prevalent in type II diabetes (T2DM), enhancing morbidity and tracking metabolic syndrome parameters. Ldlr Ϫ/Ϫ mice fed high-fat "Westernized" diets (HFD) accumulate aortic calcium primarily in the tunica media, mediated via osteogenic morphogens and transcriptional programs that induce aortic alkaline phosphatase (ALP). Because elevated TNF-␣ is characteristic of obesity with T2DM, we examined contributions of this inflammatory cytokine. Methods and Results-HFD promoted obesity, hyperglycemia, and hyperlipidemia, and upregulated serum TNF-␣ in Ldlr Ϫ/Ϫ mice. Serum haptoglobin (inflammatory marker) was increased along with aortic expression of BMP2, Msx2, Wnt3a, and Wnt7a. Dosing with the TNF-␣ neutralizing antibody infliximab did not reduce obesity, hypercholesterolemia, or hyperglycemia; however, haptoglobin, aortic BMP2, Msx2, Wnt3a, and Wnt7a and aortic calcium accumulation were downregulated by infliximab. Mice with vascular TNF-␣ augmented by a transgene (SM22-TNF␣Tg) driven from the SM22 promoter upregulated aortic Msx2, Wnt3a, and Wnt7a. Furthermore, SM22-TNF␣Tg;TOPGAL mice exhibited greater aortic ␤-galactosidase reporter staining versus TOPGAL sibs, indicating enhanced mural Wnt signaling. In aortic myofibroblast cultures, TNF-␣ upregulated Msx2, Wnt3a, Wnt7a, and ALP. ALP induction was inhibited by Dkk1, an antagonist of paracrine Wnt actions. Conclusions-TNF-␣ promote aortic Msx2-Wnt programs that contribute to aortic calcium accumulation in T2DM.
T ype II diabetes (T2DM) increasingly afflicts our dysmetabolic population, with concomitant increases in vascular disease burden. 1 Public health consequences of diabetic macrovascular disease are difficult to overestimate. Stroke, myocardial infarction, congestive heart failure, and lowerextremity amputation exact serious morbidity and economic cost. 1 Expenses associated with amputation are equivalent to the combined yearly costs of managing congestive heart failure and fatal and nonfatal myocardial infarction. 1 Lehto identified aortofemoral medial artery calcification as the most significant predictor of lower-extremity amputation. 2 A better understanding of mechanisms that control aortic calcium deposition will lead to novel strategies for improving macrovascular Windkessel function and thus disease burden.
Arterial calcification is a highly regulated form of tissue mineralization that proceeds via mechanisms resembling membranous and endochondral bone formation. 3 Osteo/chondrogenic transcription factors such as Sox9, Runx2, and Msx2 are upregulated in the mineralizing vasculature, activating expression of osteogenic enzymes and matrix proteins necessary for calcium deposition. 4 Both osteogenic and chondrogenic programs are elaborated in calcifying arterial specimens, including those from diabetic patients. 4 Rajamannan first demonstrated expression of Wnt3 and osteogenic Wnt signaling in calcifying human aortic valves. 5 The Multiethnic Study of Atherosclerosis established stepwise relationships between aortic valve calcium load and metabolic syndrome parameters. 6 Msx2-Wnt signaling participates in the aortic valve and medial calcification characteristic of T2DM in Ldlr Ϫ/Ϫ mice fed high-fat diets (HFD). 7, 8 Thus, the obesity, hyperinsulinemia, hyperglycemia, dyslipidemia, and aortic calcification induced in the Ldlr Ϫ/Ϫ mouse fed HFD recapitulates key biological features of human disease. 5, 6 Mechanisms that activate the aortic Msx2-Wnt cascade in this model have yet to be elucidated.
An emerging view of T2DM encompasses obesity-dependent low-grade systemic inflammation as a component of insulin resistance and vascular disease. 9, 10 Adipose is an endocrine tissue that elaborates multiple adipocytokines, including TNF-␣. 10 Paracrine interactions between tissue adipocytes and interstitial macrophages control production of fat-derived humoral signals. 11 Chief among the inflammatory mediators is TNF-␣, a prototypic cytokine of activated macrophages 11 that induces insulin resistance. 9,10 TNF-␣ activity of the fibro-fatty arterial adventitial layer is upregulated with diabetes. 12 Demer first identified that TNF-␣ may participate in vascular calcification, upregulating ALP (alkaline phosphate) activity as a necessary component of CVC (calcifying vascular cell) mineralization in vitro. 13 However, contributions of TNF-␣ to aortic calcification have not been studied in vivo.
In this work, we evaluated whether TNF-␣ regulates the osteogenic signals recently identified as participating in aortic calcification in diabetic Ldlr Ϫ/Ϫ mice. 7, 5 We identify that procalcific aortic Msx2-Wnt signaling cascades are entrained to TNF-␣ signals activated by HFD-induced obesity and T2DM.
Materials and Methods

Materials, Cells, and Fluorescence RT-PCR
Recombinant TNF-␣ and Dkk1 were obtained from R&D Systems. ELISA kits for haptoglobin (Life Diagnostics Inc), and TNF-␣ and Alizarin staining of aorta histologically localized calcium deposition. 7 Initial patchy calcification (A and B) progressively becomes circumferential (C and D). Medial calcification predominates (black arrows, E and F), but some atherosclerotic calcification occurs (white arrows, D, F). A skeletal control for calcium staining is included in panel F. leptin (RND Systems) were commercially obtained. Biochemical assays for cholesterol and glucose were performed using commercial assays as per the manufacturer (Thermo). The TNF-␣ neutralizing antibody infliximab 14 was purchased from Centocor. Other reagents were purchased from Sigma or Fisher. Primary mouse aortic adventitial myofibroblasts were generated as described 7 (detailed in the supplemental materials, available online at http://atvb.ahajournals. org). Fluorescence RT-PCR was used to quantify the relative mRNA accumulation of aortic osteogenic signaling molecules as previously detailed 7 (detailed in the online supplement).
Generation of SM22-TNFalphaTg and SM22-TNFalphaTg;TOPGAL Transgenic Mice
SM22-TNFalpha transgenic mice were generated as before 7 at the Washington University Mouse Genetics Core. Detailed methods are presented in the accompanying online supplement. TOPGAL mice were purchased from Jackson Laboratory, Bar Harbor, Maine.
Murine Studies and Cardiovascular Histochemistry
Male Ldlr Ϫ/Ϫ mice (Jackson Labs #002207; C57BL/6J background) were fed Picolab Rodent Diet 20 (#5053) until challenged at 2 months of age with HFD (Harlan Teklad diet TD88137; 42% fat calories, 0.15% cholesterol) for 5 weeks. All studies had 5 to 15 animals per treatment arm as indicated. Animals were dosed twice weekly with 10 g/g subcutaneous infliximab in vehicle, 15 or with vehicle (500 mg sucrose, 0.5 mg polysorbate 80, 2.2 mg monobasic sodium phosphate monohydrate, and 6.1 mg dibasic sodium phosphate dihydrate in 10 mL of sterile water as per the package insert). At the end of the treatment period, mice were fasted overnight, then euthanized following protocols approved by the institutional Animal Studies Committee. Aortic segments from the arch to the renal arteries were dissected and individually analyzed for either (1) gene expression by RT-PCR or (2) calcium content after formic acid extraction. These published methods 7 are detailed in the accompanying online supplement.
Statistics
For histological staining results, chi-square analysis was performed with Yate correction 16 to compare SM22-TNFalphaTg;TOPGAL versus TOPGAL littermates. For all other data, analyses were performed using Student t test, with data presented as the meanϮSEM.
Results
High-Fat Diets Induce TNF-␣, Low-Grade Systemic Inflammation, and Medial Artery Calcification in Ldlr ؊/؊ Mice
The male Ldlr Ϫ/Ϫ mice fed HFD typical of Western societies develop hyperglycemia, hyperinsulinemia, dyslipidemia, and obesity. 17 As observed in humans with metabolic syndrome or T2DM, 6 aortic calcification is enhanced in male Ldlr Ϫ/Ϫ with HFD-with the concomitant induction of osteogenic gene regulatory programs in aortic tissues. 8 Alizarin red staining for calcium deposition reveals that, after 1 month of HFD, patchy calcium deposition is observed in the aortic tunica media ( Figure 1A and 1B). After 6 months of HFD, both medial and atherosclerotic calcium deposition are visible in proximal and distal thoracic aortic segments, with greater staining observed in the tunica media ( Figure 1C and 1D ). As observed in the coronary arteries ( Figure 1E ), regions of aortic media lacking overlying atheroma stained with Alizarin red with an intensity approximating that of mineralizing neonatal mouse bone ( Figure 1F ).
Prior studies showed that TNF-␣ plays a critical role in CVC mineralization in vitro. 13 Because TNF-␣ signaling is implicated in pathogenesis of T2DM, 9 we evaluated serum TNF-␣ levels in Ldlr Ϫ/Ϫ mice. Under basal conditions, fasting TNF-␣ levels were undetectable; however, serum TNF-␣ rose to 8.4Ϯ3.6 g/L in animals fed HFD (Pϭ0.03). Moreover, HFD feeding significantly induced serum haptoglobin levels-a marker of inflammatory cytokine signaling-from 0.46Ϯ0.03 mol/L to 1.27Ϯ0.16 (Pϭ0.025). To identify whether endogenous TNF-␣ contributed to diet-induced inflammatory responses in Ldlr Ϫ/Ϫ mice, we tested the effects of infliximab (INX)-a clinically useful TNF-␣-neutralizing antibody-implementing a validated dosing regimen. 14 Circulating levels of haptoglobin were significantly reduced by infliximab, to 0.93Ϯ0.12 mol/L (Pϭ0.046); parallel reductions in another serum inflammation marker, hemopexin, were also observed (not shown). Infliximab did not reduce the weight gain, hyperglycemia, hypercholesterolemia, or hyperleptinemia induced by HFD (Table) . Thus, TNF-␣ is upregulated in Ldlr Ϫ/Ϫ mice fed HFD. Infliximab administration reduced inflammation-reflected in the serum inflammatory biomarker haptoglobin-with little effect on weight gain, hyperglycemia, hypercholesterolemia, and hyperleptinemia induced by HFD consumption.
Aortic Osteogenic BMP2-Msx2-Wnt Programs Induced by HFD Are Inhibited by Infliximab, With Concomitant Reduction in Aortic Calcium Content
In response to HFD, Ldlr Ϫ/Ϫ mice accrue arterial calcium accumulation as revealed by Alizarin red, most notable in the tunica media of the aorta and the coronary arteries ( Figure 1 ). We previously demonstrated that HFD upregulated both aortic BMP2 and Msx2 in Ldlr Ϫ/Ϫ mice. 8 Of note, paracrine Wnt signals activated by aortic Msx2 expression contribute to medial calcium accrual, 7 and a related paracrine Wnt signaling cascade controls BMP2-dependent ossification in cultured osteoblasts. 18 Therefore, we wished to assess whether antagonizing TNF-␣ 
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signaling with infliximab would ameliorate procalcific aortic BMP2, Msx2, and Wnt signaling in the Ldlr Ϫ/Ϫ mouse. As shown in Figure 2A , HFD upregulated aortic mRNA accumulation for BMP2, Msx2, Wnt3a, and Wnt7a as described. 7, 8 Significantly, aortic expression of these HFD-induced signals was downregulated by infliximab ( Figure 2A ). This was paralleled by infliximab-induced downregulation of the cytokine OPN (osteopontin), 19 but not Runx2 or Dkk1 ( Figure 2B ). We next assessed effects of infliximab on aortic calcium accumulation after 5 weeks of HFD, an early disease stage when medial calcification predominates ( Figure 1A) , by quantifying acidextractable calcium. Ldlr Ϫ/Ϫ animals were placed on HFD as before, and treated with either vehicle (nϭ10) or 10 g/gm infliximab (nϭ5) twice weekly for 5 weeks. Aortic matrix calcium accumulation was reduced by 30% in animals treated with infliximab ( Figure 2C , from 1.44 to 0.99 g calcium/gm aortic tissue; PϽ0.05). Thus, infliximab, a specific TNF-␣ neutralizing antibody, reduces aortic proosteogenic signaling and early calcium accumulation associated with HFD feeding in male Ldlr Ϫ/Ϫ mice.
TNF-␣ Directly Induces Msx2-Wnt Signaling in Aortic Myofibroblasts In Vitro
Endothelial production of BMP2 is enhanced by TNF-␣, 20 and BMP2 promotes osteogenic Msx2 8 and Wnt 18 signals. We wished to assess whether TNF-␣ might exert direct actions on aortic Msx2-Wnt signaling. 7 We focused on primary aortic adventitial myofibroblasts, a mural progenitor cell population that expresses Msx2 and generates vascular cells that calcify in vivo and in vitro. 7, 8, 21 As shown in Figure 3A , TNF-␣ dose-dependently increased Msx2 mRNA accumulation in aortic adventitial myofibroblasts. Induction was an immediate-early response, because cycloheximide treatment did not prevent Msx2 upregulation (not shown). Subsequent time course studies revealed that Msx2 induction preceded that of BMP2 in myofibroblasts ( Figure 3B) . Moreover, addition of the BMP2 inhibitor, noggin, 18 did not alter TNF-␣ induction of Msx2 (not shown). We next evaluated effects of TNF-␣ on expression of Wnt1, Wnt3a, and Wnt7a-canonical Wnt ligands previously identified as components of the aortic Msx2-Wnt signaling cascade. 7 TNF-␣ treatment significantly upregulated expression of Wnt3a and Wnt7a, but had no effect on Wnt1 ( Figure  3C ). TNF-␣ induction of these 2 canonical Wnt ligands was functionally important; recombinant Dkk1-an antagonist of Wnt signaling via LRP5 and LRP6 18 -inhibited TNF-␣ upregulation of bone ALP (Figure 3D ), a key genomic target of osteogenic Wnt signaling. 7, 18 Thus, TNF-␣ can stimulate Msx2-Wnt signaling in aortic adventitial myofibroblasts. Figure 1A and 1B) .
The SM22-TNFalpha Transgene Upregulates Aortic Msx2 Expression and Canonical Wnt Signaling In Vivo
To confirm that TNF-␣ upregulates aortic Msx2-Wnt signaling in vivo, we generated SM22-TNFalpha transgenic (Tg) mice as a model for study. The SM22 promoter has proved useful for directing vascular smooth muscle cell (VSMC)specific gene expression in vivo. 22 Therefore, we assembled an SM22 promoter-TNF-␣ cDNA expression construct (Fig-ure 4A) , and generated and characterized SM22-TNFalphaTg mice. SM22-TNFalphaTg mice exhibit 2.4-fold elevated aortic TNF-␣ message by RT-PCR as compared with nontransgenic littermates (Pϭ0.0003). Moreover, as observed in vitro, the SM22-TNFalpha transgene significantly upregulated expression of aortic BMP2, Msx2, Wnt3a, and Wnt7a gene expression in vivo ( Figure 4B ). We wished to assess whether the TNF-␣ transgene was capable of augmenting aortic Wnt signaling in vivo; this was important, because TNF-␣ exerts time-dependent biphasic rapid inductive/delayed suppressive effects on myofibroblast Dkk1 expression (unpublished observations). The TOPGAL (TCF/LEF optimal promoter ␤-galactosidase/LacZ reporter) mouse has been used to monitor activation of canonical Wnt signaling in vivo. 7, 23 Therefore, we generated SM22-TNFalphaTg;TOPGAL mice (mixed B6:CD1 background), and compared aortic LacZ staining to that observed with TOPGAL littermates lacking SM22-TNFalpha transgene. Four of 5 SM22-TNFalphaTg:TOPGAL mice exhibited prominent LacZ staining of mural cells ( Figure 4C , right panels). By contrast, no LacZ staining was observed in 5 of 5 TOPGAL siblings lacking the SM22-TNFalpha transgene ( Figure 4C , left panels; Pϭ0.05, Yate corrected chi-squared test). Identical results were observed in coronary arteries ( Figure 4D ). Thus, TNF-␣ promotes aortic Msx2, Wnt3a, and Wnt7a expression, and augments aortic canonical Wnt signaling in vivo.
Discussion
The epidemic of diabetes and obesity assailing Westernized societies threatens to interact with the prevalent, age-related incidence of aortic disease to increase macrovascular disease burden. 3 Primary prevention strategies are critically important; however, as many as one-third of patients with T2DM may be unaware of their disorder-and vascular disease processes that threaten life, limb, and autonomy progress from the earliest phases of the dysmetabolic state. 1,2 A better understanding of aortofemoral disease in T2DM is necessary to develop new strategies to address this burgeoning clinical need.
The Ldlr Ϫ/Ϫ mouse has emerged as one useful model for studying macrovascular injury in response to T2DM. 17 When fed HFD, these mice become obese, with concomitant hyperglycemia and dyslipidemia. 17 Unlike the Apoe Ϫ/Ϫ mouse-a model of atherosclerosis in the absence of hyperglycemia and obesity 17 Ldlr Ϫ/Ϫ mice fed the HFD elaborate key features of metabolic syndrome. 17 The relationships between metabolic syndrome parameters and aortic valve calcification in humans were recently established. 6 Thus, the Ldlr Ϫ/Ϫ murine model faithfully recapitulates key aortic pathobiology, including aortic calcification, entrained to the metabolic syndrome-T2DM continuum of disease severity.
Using this model, we describe a novel TNFalpha-Msx2-Wnt signaling axis that contributes to the pathobiology of diabetic macrovascular disease. TNF-␣ is the prototypic inflammatory cytokine that exerts global influences on metabolism and innate immunity. 9, 10 The TNF-␣ neutralizing antibody infliximab downregulated aortic Msx2-Wnt programs without improving fasting serum glucose or choles- terol. Thus, based on the prior studies of Demer 24 and our results, we anticipate that programs elicited by TNF-␣ divert multipotent CVCs-macrovascular mural pericytes 25 -to the osteogenic lineage via activation of the Msx2-Wnt pathway. Of note, in the dyslipidemic Apoe Ϫ/Ϫ mouse, migratory mesenchymal progenitors are recruited from the adventitia to populate mural VSMC populations. 26 This may include the pericytes, 25 myofibroblasts, 8 and CVCs 24 that program arterial calcification, because surgical resection of the adventitia reduces arterial calcification. 21 Our in vitro studies have emphasized responses in adventitial myofibroblast preparations. Like CVCs generated from tunica media, 24 aortic adventitial myofibroblast preparations are heterogeneous for calcifying cells. 8 As surface markers emerge that permit isolation of VSMCs at each stage of differentiation, it will be important to determine whether TNF-␣ regulation of arterial Msx2-Wnt cascades change with phenotypic maturation. Proosteogenic signals are counter-balanced by critically important negative regulators of arterial mineral deposition. Chief among these are OPN, inorganic pyrophosphate, fetuin, osteoprotegerin, and matrix Gla protein (MGP). 27, 28 Regulatory cross-talk between proosteogenic signals and these mineralization inhibition mechanisms has recently been described. 3 BMP2 upregulates ALP, the ectoenzyme that degrades tissue pyrophosphate-a critical inhibitor of biomineralization and secretagogue for OPN. 19 For full elaboration of the vascular tissue mineralization process, these important defense mechanisms must become compromised with disease progression.
Other metabolic insults-such as the hyperphosphatemia, hypercalcemia, and oxidative stress of uremia 29 -clearly contribute to vascular calcium load via phosphate transporter activation of Cbfa1/Runx2. 30 Runx2 is an osteogenic and chondrogenic transcription factor exquisitely regulated by posttranslation modifications, subnuclear localization, and modulatory protein-protein interactions. 30 With atherosclerotic calcification, endochondral mineralization programs are recruited, primarily dependent on Runx2 and Sox9. 4 Oxysterols generated by lipoprotein oxidation enhance Runx2dependent mineralization in culture. 31, 32 In the male Ldlr Ϫ/Ϫ mouse fed HFD, Alizarin red staining for calcium accumulation reveals that medial calcification predominates as obesity and T2DM ensue. However, with prolonged dietary challenge of Ldlr Ϫ/Ϫ mice, atherosclerotic calcification clearly becomes super-imposed in the aorta (Figure 1 ). Whether the TNF-␣-dependent Msx2-Wnt pathways and Runx2-regulated programs differentially contribute with disease progression has yet to be explored in this model.
Of note, biomineralization can be nucleated by phospholipid-rich matrix vesicles 33 and apoptotic bodies, 33 or by devitalized elastin. 34 Thus, disease pathobiology and histological characteristics will differ depending on the mechanisms used to initiate vascular calcium deposition. In early lesions of the Ldlr Ϫ/Ϫ mouse, arterial calcium deposition visualized by Alizarin red staining is overlapping yet distinct from that seen with von Kossa stain for phosphate deposition (unpublished observations); similar observations were noted almost 40 years ago by Puchtler et al in studies of early human atherosclerotic lesions. 35 Moreover, changes in bone resorption-coupled with common, clinically relevant agents such as warfarin that cripple Gla-dependent inhibitors of calcification-can enhance elastin-based arterial calcification by perturbing serum nucleator/nucleation inhibitor homeostasis. 36, 37 Indeed, T2DM is frequently accompanied by chronic kidney disease that will increase bone turnover. 29 Thus, a comprehensive understanding of arterial calcification will require integration of the diverse mechanisms that control vascular mineral deposition-and recognition that mechanistic contributions likely change with clinical setting and disease stage. 3 We demonstrate that aortic mineralization programs characteristic of membranous bone formation 38 are entrained to signals elicited by TNF-␣. TNF-␣ promotes aortic Msx2 expression and enhances procalcific arterial Msx2-Wnt cascades in vitro and in vivo. Treatment of aortic myofibroblasts with Dkk1, an antagonist of paracrine Wnt signals, inhibits TNF-␣ induction of ALP, an early osteogenic gene downstream of Msx2-Wnt activation. Of note, the antiinflammatory compound salicylate also downregulates aortic Msx2 in vivo (not shown). Thus, strategies that attenuate proinflammatory TNF-␣ signals may help ameliorate aortic calcium accumulation.
There are limitations to our study. The magnitude of aortic Msx2 and Wnt message downregulation by infliximab was consistently greater than the observed inhibition of aortic calcium accumulation (30% reduction) at this early disease stage. Regulatory mechanisms in addition to those emphasized in this study must also contribute. These include elastin metabolism, 34, 39 fetuin-and calcium phosphate-dependent regulation of matrix vesicle metabolism, 33 osteoprotegerininhibited cytokines, 3, 36 and other emerging inhibitors of calcification. 25 Terkeltaub 40 recently extended the seminal observations of Giachelli 19 that highlight the importance of vascular OPN; pyrophosphate generating systems not only inhibit mineralization directly, but also stimulate secretion of OPN 40 -a potent inhibitor of vascular calcium deposition and mediator of calcium egress. 19 Of note, infliximab therapy downregulates aortic OPN, consistent with its antiinflammatory properties but potentially compromising beneficial actions of OPN that limit vascular calcium deposition. 19 Moreover, unlike effects on Msx2-Wnt signals, infliximab did not reverse HFD-induced aortic Runx2 expression. With prolonged dietary challenge, endochondral mineralization mechanisms driven by Runx2 may continue unabated, even when Msx2-Wnt signals are mitigated. Finally, key redox enzymes impact the type and extent of oxidative stress-and thus generation of vascular oxysterols from LDL. 31, 32 Oxysterols that drive Runx2 activation and endochondral mineralization 31, 32 likely participate in aortic calcium load with prolonged dyslipidemia. Future studies will evaluate whether TNF-␣ differentially impacts early versus late calcification mechanisms as disease progresses. Nonetheless, the identification that aortic calcification of T2DM occurs in part via TNF-␣ driven Msx2-Wnt signaling 5 provides insights useful for developing novel multimodality strategies 5, 36 to ameliorate diabetic vascular disease. 2, 6 
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